Defence industrial platform, precision mRNA therapeutics, TCR bispecific therapeutics

Onodrim Industries, SRTD Biotech, T-Therapeutics — $300M for defence, €31.5M for RNA and $133M for bispecifics — Daily News November 9, 2026

01:48 • 09/11/2026
Listen on Spotify🇮🇹 Podcast in Italian

About this episode

Three European rounds fund different ways of building capacity: consolidating the defence industrial base, making RNA therapies selective and advancing bispecific drugs towards the clinic. Capital speeds up execution, but integrated acquisitions, preclinical evidence and clinical results remain the decisive tests.

Europe's most interesting startup stories. Every week.

No spam. Unsubscribe anytime.

Main news

Startups mentioned

Listen to the episode

Listen on Spotify🇮🇹 Podcast in Italian
🎙️ Scalable Podcast — European startup stories · 🇮🇹 in Italian
Spotify 🎧 Apple